Log in to search using one of your social media accounts:

 

“Screening Pill” Could Offer Noninvasive Breast Cancer Screening Method
Researchers have developed a “disease screening pill” that could allow for a noninvasive and safe method for detecting breast cancer using only near-infrared light. (Source: CancerNetwork)
Source: CancerNetwork - May 18, 2018 Category: Cancer & Oncology Authors: Dave Levitan Tags: Breast Cancer News Source Type: news

Warning that breast cancer still seen as ‘white woman’s disease’
Experts have encouraged black women to visit their GP if they notice any changes in their breasts, in the wake of research suggesting breast cancer is often perceived as a “disease of whiteness”. (Source: Nursing Times)
Source: Nursing Times - May 18, 2018 Category: Nursing Source Type: news

Classical singer who battled breast cancer says doctors should have urged her to freeze her eggs
EXCLUSIVE: Joanna Forest, 39, who lives in Essex with her husband James, said she may have tried for a baby by now, had doctors explained the situation properly to her two decades ago. (Source: the Mail online | Health)
Source: the Mail online | Health - May 18, 2018 Category: Consumer Health News Source Type: news

DBT improves diagnostic mammography, too
It's not just for screening anymore: A new study found that using digital breast...Read more on AuntMinnie.comRelated Reading: ARRS: Added radiation exposure from DBT is within limits DBT improves breast cancer screening in young women FDA authorizes ACR to accredit DBT devices DBT know-how boosts FFDM recall, cancer detection rates Deep learning may produce sharp reductions in DBT dose (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 18, 2018 Category: Radiology Source Type: news

Particle shows promise for treating the deadliest type of breast cancer
(University of Southern California - Health Sciences) USC researchers have pinpointed a remedy to thwart a protein that helps the metastatic spread of breast cancer, a leading cause of death for women. The findings appear today in Nature Communications. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 18, 2018 Category: Cancer & Oncology Source Type: news

Breast cancer treatment time could be HALVED
British research from the University of Warwick and the University of Cambridge has revealed the amount of time a person needs on herceptin could be halved from 12 months to six (stock). (Source: the Mail online | Health)
Source: the Mail online | Health - May 17, 2018 Category: Consumer Health News Source Type: news

Hormone Therapy and Risk for Cancer in BRCA1 Mutation Carriers Hormone Therapy and Risk for Cancer in BRCA1 Mutation Carriers
Dr Andrew Kaunitz discusses the impact of hormone therapy on risk for breast cancer in BRCA carriers undergoing risk-reduction surgery.Medscape Ob/Gyn (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 17, 2018 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Commentary Source Type: news

Nigeria:Roche Launches Innovative Medicine Against Breast Cancer in Nigeria
[This Day] Swiss multinational, Roche has launched the subcutaneous formulation of Herceptin, its flagship breast cancer drug in Nigeria. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 17, 2018 Category: African Health Source Type: news

Shorter-Duration Trastuzumab as Effective for HER2+ Early Breast Cancer
Women with HER2-positive early breast cancer achieved similar disease-free survival with 6 months of adjuvant trastuzumab compared with a 12-month duration, according to the phase III PERSEPHONE trial. (Source: CancerNetwork)
Source: CancerNetwork - May 17, 2018 Category: Cancer & Oncology Authors: Leah Lawrence Tags: Conferences/ASCO Breast Cancer HER2-Positive Breast Cancer SiteTerms/www.cannabissciencetech.com/News Source Type: news

Breast Cancer Patients May Shorten Herceptin Regimen: Study
Title: Breast Cancer Patients May Shorten Herceptin Regimen: StudyCategory: Health NewsCreated: 5/16/2018 12:00:00 AMLast Editorial Review: 5/17/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - May 17, 2018 Category: Cancer & Oncology Source Type: news

The Cost of Contralateral Prophylactic Mastectomy The Cost of Contralateral Prophylactic Mastectomy
In this article, the economic value of contralateral prophylactic mastectomy among women with early-stage unilateral breast cancer is explored.Plastic and Reconstructive Surgery (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 17, 2018 Category: Consumer Health News Tags: Plastic Surgery & Aesthetic Medicine Journal Article Source Type: news

New guidelines to help clinicians manage GSM in women with breast cancer
(The North American Menopause Society (NAMS)) Although the genitourinary syndrome of menopause (GSM) is more prevalent in survivors of breast cancer than in other menopausal women, it is commonly undiagnosed and untreated. This led NAMS and ISSWSH to form a multidisciplinary Consensus Panel to develop recommendations for clinicians to manage GSM in women with or at high risk for breast cancer. The recommendations are published online in NAMS' official journal, Menopause. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 17, 2018 Category: International Medicine & Public Health Source Type: news

Immune cell provides cradle for mammary stem cells
(Princeton University) Researchers have made new discoveries about how an immune cell known as the macrophage, which normally fights infection by swallowing foreign invaders, nurtures mammary gland stem cells through a chemical signaling molecule. The study may provide important clues about the roles of macrophages in breast cancer progression. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 17, 2018 Category: Cancer & Oncology Source Type: news

Stem cell signaling drives mammary gland development and -- maybe -- breast cancer
(University of Pennsylvania) A unique tissue type in many ways, the mammary gland is cloaked in mysteries that scientists puzzle over. In a paper in Science, the University of Pennsylvania's Rumela Chakrabarti and colleagues describe a newly identified connection between mammary stem cells and macrophages, a type of immune cell. The crosstalk between these two cell types is crucial for mammary gland development, and may also figure into the biology of breast cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 17, 2018 Category: Cancer & Oncology Source Type: news

Improving survival in pancreatic cancer with platinum-based chemotherapy
(Johns Hopkins Medicine) A small study of adults with the most common form of pancreatic cancer adds to evidence that patients with BRCA1 or BRCA2 gene mutations long linked to a high risk of breast cancer have poorer overall survival rates than those without the mutations. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 17, 2018 Category: International Medicine & Public Health Source Type: news

Good News on Early Breast Cancer: Herceptin Treatment Can Be Shortened
A large, new study shows that the treatment regimen, typically recommended for a year, can be just as effective at 6 months, reducing serious side effects and costs. (Source: NYT Health)
Source: NYT Health - May 16, 2018 Category: Consumer Health News Authors: DENISE GRADY Tags: Breast Cancer Herceptin (Drug) Genentech Inc Earl, Helena M side effects Source Type: news

Breast Cancer Patients May Shorten Herceptin Regimen: Study
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - May 16, 2018 Category: Cancer & Oncology Tags: Gynecology, Oncology, News, Source Type: news

Roche breast cancer drug treatment time can be halved - study
(Reuters) - Treating early stage breast cancer patients for just six months with Roche's Herceptin works as well as the current 12-month regimen, researchers who conducted a large clinical trial said on Wednesday. (Source: Reuters: Health)
Source: Reuters: Health - May 16, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Shorter drug treatment OK for many breast cancer patients
New research suggests that many women with a common and aggressive form of breast cancer that is treated with Herceptin can get by with six months of the drug instead of the usual 12 (Source: ABC News: Health)
Source: ABC News: Health - May 16, 2018 Category: Consumer Health News Tags: Health Source Type: news

For Women With Early Breast Cancer, Herceptin Treatment Can Be Much Shorter
A large, new study shows that the treatment regimen, typically recommended for a year, can be just as effective at 6 months, reducing serious side effects and costs. (Source: NYT Health)
Source: NYT Health - May 16, 2018 Category: Consumer Health News Authors: DENISE GRADY Tags: Breast Cancer Herceptin (Drug) American Society of Clinical Oncology Cambridge University side effects Genentech Inc Source Type: news

Mathematical Modeling May Guide Cancer Treatment & #039;Holidays & #039;
A Moffitt team suggests mathematical modeling may guide the optimal cancer treatment dosing approach better than MTD. (Source: CancerNetwork)
Source: CancerNetwork - May 16, 2018 Category: Cancer & Oncology Authors: John Schieszer Tags: Breast Cancer Melanoma News Source Type: news

Multi-epitope T-cell Vaccine Shows Promise in Ovarian, Breast Cancer
TPIV200 stimulates T cells to attack ovarian and triple negative breast tumor cells that over-express the folate receptor alpha protein. (Source: CancerNetwork)
Source: CancerNetwork - May 16, 2018 Category: Cancer & Oncology Authors: By John Schieszer Tags: Breast Cancer Immuno Oncology News Ovarian Cancer Source Type: news

Breast Cancer Patients May Shorten Herceptin Regimen: Study
WEDNESDAY, May 16, 2018 -- For years, the drug Herceptin has helped women with an aggressive form of breast cancer beat the disease. But there's one downside: In a minority of cases, the drug can trigger heart damage. Now, a new study finds that... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 16, 2018 Category: General Medicine Source Type: news

Medical News Today: Is breast asymmetry linked to breast cancer?
Many women have slight differences in the size or shape of their breasts. Breast asymmetry is usually not a cause for concern, though substantial asymmetry in the size or density of breasts may suggest an increased risk of breast cancer. A mammogram can look for abnormalities and diagnose the cause of breast asymmetry. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 16, 2018 Category: Consumer Health News Tags: Women's Health / Gynecology Source Type: news

Shorter trastuzumab treatment for HER2+ breast cancer can be as effective, with fewer cardiac side-effects
(American Society of Clinical Oncology) A phase III randomized clinical trial of 4,088 women with HER2-positive, early-stage breast cancer found that taking trastuzumab (Herceptin) for 6 months was non-inferior to the current standard of 12 months. The disease-free survival rate at four years was 89.4 percent with 6 months of therapy and 89.8 percent with 12 months of therapy. In addition, only 4 percent of women in the 6-month arm stopped trastuzumab early because of cardiac problems, compared with 8 percent in the 12-month arm. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 16, 2018 Category: International Medicine & Public Health Source Type: news

Diagnosing breast cancer with an imaging pill
(American Chemical Society) For women, mammograms are a sometimes uncomfortable, but necessary, annual ritual. But this procedure doesn't always provide accurate results, and it exposes women to X-rays. In a study appearing in ACS' journal Molecular Pharmaceutics, scientists report that they have developed a non-invasive 'disease screening pill' that can make cancerous tumors light up when exposed to near-infrared light in mice without using radiation. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 16, 2018 Category: Cancer & Oncology Source Type: news

A 'dirty bomb' battles cancer metastasis
(Northwestern University) Scientists have developed a new compound that inhibits the spread of cancer cells, which is what makes the disease so lethal. The compound, metarrestin, significantly reduced metastasis by human prostate, pancreatic and breast cancer transplanted into mice. Mice treated with it had fewer metastatic tumors and lived longer than mice that did not receive treatment. Metarrestin is being submitted to the FDA as an investigational drug. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 16, 2018 Category: Cancer & Oncology Source Type: news

Improving Adherence to Endocrine Therapy in Women With HR-Positive Breast Cancer
Here, we discuss how to improve adherence to endocrine therapy in women with HR-positive breast cancer, as well as the side effects and the reasons for discontinuation. (Source: CancerNetwork)
Source: CancerNetwork - May 15, 2018 Category: Cancer & Oncology Authors: Charles L. Shapiro, MD Julia P. Brockway, MD Tags: Breast Cancer Oncology Journal Source Type: news

Mathematical method could automatize, enhance breast cancer diagnosis
Using mathematical models, researchers are developing algorithms and software that could automatize and enhance breast cancer diagnosis. (Source: Health News - UPI.com)
Source: Health News - UPI.com - May 15, 2018 Category: Consumer Health News Source Type: news

CDK4/6 Inhibitors: Game Changers in the Management of Hormone Receptor –Positive Advanced Breast Cancer?
Here, we review the current use of and potential next directions for CDK4/6 inhibitors in the treatment of patients with HR-positive breast cancer. (Source: CancerNetwork)
Source: CancerNetwork - May 15, 2018 Category: Cancer & Oncology Authors: Maria Raquel Nunes, MD Mirat Shah, MD Vered Stearns, MD Tags: Breast Cancer Oncology Journal Review Article Source Type: news

Mathematical methods for diagnosing breast cancer
(Kaunas University of Technology) The team of researchers at Kaunas University of Technology, Lithuania are developing mathematical methods which could help diagnose breast cancer. Applying deep learning method, the researchers are aiming to 'teach' computers to recognize malignant lesions, which would allow at least partially automatize and enhance the accuracy of diagnosing breast cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 15, 2018 Category: Cancer & Oncology Source Type: news

Axillary Ultrasound After Chemotherapy: Mayo Clinic Radio Health Minute
In this Mayo Clinic Radio Health Minute, Dr. Judy Boughey explains how breast cancer care is being tailored to a patients needs. To listen, click the link below. Axillary Ultrasound after Chemo (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - May 15, 2018 Category: Databases & Libraries Source Type: news

Multigene Sequencing Rapidly Replacing BRCA Tests Multigene Sequencing Rapidly Replacing BRCA Tests
Among women diagnosed with breast cancer, during the past 2 years, the use of multigene testing has risen dramatically, while testing only for BRCA mutations has dropped.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 14, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Breast cancer warning - five symptoms that you should never ignore
BREAST cancer symptoms usually begin with a lump, but all signs should be checked by a doctor. These are the symptoms you should never ignore - is pain one of the symptoms of a deadly tumour? (Source: Daily Express - Health)
Source: Daily Express - Health - May 14, 2018 Category: Consumer Health News Source Type: news

Targeting AXL Could Slow Metastasis in HER2-Positive Breast Cancer
New research has found that expression of AXL is correlated with poor outcomes in patients with HER2-positive breast cancer. (Source: CancerNetwork)
Source: CancerNetwork - May 14, 2018 Category: Cancer & Oncology Authors: Dave Levitan Tags: Breast Cancer HER2-Positive Breast Cancer SiteTerms/www.cannabissciencetech.com/News Source Type: news

RoomLab CEO: On Fighting Cancer, A Surprise Pregnancy And Raising Investment
“It was an enormous shock,” says Suzann Bozorgi after a deep breath. The entrepreneur is still new to talking about the breast cancer diagnosis that rocked her life. Yet her mental and physical experience of cancer have directly influenced her the two businesses she's founded. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 14, 2018 Category: Pharmaceuticals Authors: Kitty Knowles, Forbes Staff Source Type: news

Study hints at new target to improve immune therapy in triple-negative breast cancer
(University of Colorado Anschutz Medical Campus) University of Colorado Cancer Center study shows that Eya3 may regulate the immune response to a tumor, implying that anti-Eya3 therapies may improve checkpoint inhibitors against triple-negative breast cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 14, 2018 Category: Cancer & Oncology Source Type: news

University of Colorado Cancer Center Study Hints at New Target to...
Eya3 inhibition could be an attractive strategy to increase effectiveness of anti-PD-L1 immunotherapies against triple-negative breast cancer.(PRWeb May 14, 2018)Read the full story at http://www.prweb.com/releases/2018/05/prweb15477653.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 14, 2018 Category: Pharmaceuticals Source Type: news

How Math Can Potentially Reduce Unnecessary Breast Biopsies
The perceived risk of missing a breast cancer diagnosis with imaging studies often leads to unnecessary breast biopsies, according to a new report published in the American Journal of Roentgenology. The authors showed how statistical methods can be used to downgrade the risk classification of breast masses to reduce the need for unnecessary biopsies. Clinicians from San Antonio, TX-based Seno Medical and medical center collaborators from the University of Texas (MD Anderson and U of Texas Health Sciences Center) co-authored the report. The authors studied a statistical calculation known as the negative ...
Source: MDDI - May 11, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Imaging Source Type: news

Breast cancer scare recalls the value of collecting evidence
Research and knowledge are not always enough — people must also notice them (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - May 11, 2018 Category: Pharmaceuticals Source Type: news

Could a pill outperform mammograms?
Researchers have developed an ingestible pill that causes breast tumors to...Read more on AuntMinnie.comRelated Reading: JAMA: Women need to be aware of mammography's harms How serious is the risk of breast cancer overdiagnosis? Is the mammography debate an example of 'fake science'? Women still value mammography's benefits over 'harms' ACR reaffirms support for annual mammography at 40 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 10, 2018 Category: Radiology Source Type: news

Multigene test increasingly used to assess breast cancer risk
New research suggests women are increasingly foregoing BRCA tests, opting instead for more comprehensive tests that detect mutations in multiple genes. (Source: Health News - UPI.com)
Source: Health News - UPI.com - May 10, 2018 Category: Consumer Health News Source Type: news

Zimbabwe:Breast Cancer Victim Seeks Help
[The Herald] A Harare woman who was diagnosed with breast cancer is appealing for financial assistance to buy medication. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 10, 2018 Category: African Health Source Type: news

Medical News Today: Body clock gene may protect against breast cancer
One of the genes that regulate our circadian rhythm might also contribute to the normal development of mammary glands and protect against breast cancer. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 10, 2018 Category: Consumer Health News Tags: Breast Cancer Source Type: news

Bioimpedance Spectroscopy Spots Breast Cancer-related Lymphedema Early Bioimpedance Spectroscopy Spots Breast Cancer-related Lymphedema Early
Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - May 9, 2018 Category: Surgery Tags: Hematology-Oncology News Source Type: news

Breast cancer: Working shifts could impact your chances of developing condition
BREAST cancer research has hinted at a possible new cause of the condition. Disrupting the body clock in women may lead to an increased risk of breast cancer, through activities such as late working the night shift. (Source: Daily Express - Health)
Source: Daily Express - Health - May 9, 2018 Category: Consumer Health News Source Type: news

Breast cancer breakthrough: Working shifts could impact your chances of developin
BREAST cancer research has hinted at a possible new cause of the condition. Disrupting the body clock in women may lead to an increased risk of breast cancer, through activities such as late working the night shift. (Source: Daily Express - Health)
Source: Daily Express - Health - May 9, 2018 Category: Consumer Health News Source Type: news

Maryland woman fired after cancer diagnosis awarded $113K
A Maryland woman who was fired weeks after telling her employer she had breast cancer has been awarded more than $100,000 (Source: ABC News: Health)
Source: ABC News: Health - May 9, 2018 Category: Consumer Health News Tags: Health Source Type: news

Lab Study Shows HER2 Inhibitor Lapatinib Can Induce Cell Proliferation
A laboratory study has found that the HER2 inhibitor lapatinib used to slow HER2-positive breast cancer can actually induce tumor growth in some circumstances. (Source: CancerNetwork)
Source: CancerNetwork - May 8, 2018 Category: Cancer & Oncology Authors: Dave Levitan Tags: Breast Cancer HER2-Positive Breast Cancer SiteTerms/www.cannabissciencetech.com/News Source Type: news

Could this new pill replace breast screening?
One in three women who undergo breast cancer treatment did not need to; their benign masses were mistaken as cancerous in scans. A new pill by the University of Michigan hopes to change that. (Source: the Mail online | Health)
Source: the Mail online | Health - May 8, 2018 Category: Consumer Health News Source Type: news